The levels of plasma S100A1, NF-κB p65, and IL-6 were not statistically significantly different between the MCI and SCI groups, and it was conjectured that these inflammatory markers might need to reach a specific volume of cerebral infarction before their differences could be revealed, but the specific boundaries needed to be further investigated. The gene discussed is IL6; the disease is cerebral infarction.